3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima

Journal of Clinical Investigation

Volumn 99, Issue 9, 1997, Pages 2075-2081

  Hazen, Stanley L ^a   Heinecke, Jay W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Atherosclerosis   (United States)

Author keywords

atherosclerosis; halogenation; inflammation; phagocyte; vascular disease

Indexed keywords

HALIDE; HYDROGEN PEROXIDE; HYPOCHLOROUS ACID; LOW DENSITY LIPOPROTEIN; MARKER; MYELOPEROXIDASE; OXIDIZING AGENT; TYROSINE DERIVATIVE;

AORTA INTIMA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; HALOGENATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID OXIDATION; PHAGOCYTE; PRIORITY JOURNAL; REACTION ANALYSIS;

EID: 0030979720     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119379     Document Type: Article

References (53)

1. Brown, M.S., and J.L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science (Wash. DC). 232:34-47.
2. Witztum, J.L., and D. Steinberg. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-1792.
3. Berliner, J. A., and J. W. Heinecke. 1996. The role of oxidized lipoproteins in atherogenesis. Free Rad. Biol. Med. 20:707-727.
4. Daugherty A., J.L. Dunn, D.L. Rateri, and J.W. Heinecke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444.
5. Klebanoff, S.J., and R.A. Clark. 1978. In The Neutrophil: Function and Clinical Disorders. Elsevier/North Holland Biomedical Press, Amsterdam. 447-451.
6. Harrison, J.E., and J. Schultz. 1976. Studies on the chlorinating activity of myeloperoxidase. J. Biol. Chem. 251:1371-1374.
7. Foote, C.S., T.E. Goyne, and R.I. Lehrer. 1981. Assessment of chlorination by human neutrophils. Nature (Lond.). 301:715-716.
8. Albrich, J.M., C.A. McCarthy, and J.K. Hurst. 1981. Biological reactivity of hypochlorous acid: implications for microbicidal mechanisms of leukocyte myeloperoxidase. Proc. Natl. Acad. Sci. USA. 78:210-214.
9. Heinecke, J.W., W. Li, H.L. Daehnke, and J.A. Goldstein. 1993. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages. J. Biol. Chem. 268:4069-4077.
10. Savenkova, M.I., D.M. Mueller, and J.W. Heinecke. 1994. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 269:20394-20400.
11. Rosenfeld, M.E., W. Palinski, S. Yla-Herttuala, S. Butler, and J.L. Witztum. 1990. Distribution of oxidation-specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis. 10:336-349.
12. Thomas, E.L., M.M. Jefferson, and M.B. Grisham. 1982. Myeloperoxidase-catalyzed incorporation of amines into proteins: role of hypochlorous acid and dichloramines. Biochemistry. 21:6299-6308.
13. Weiss, S.J., R. Klein, A. Slivka, and M. Wei. 1982. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J. Clin. Invest. 70:598-607.
14. Heinecke, J.W., W. Li, D.M. Mueller, A. Bohrer, and J. Turk. 1994. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry. 33:10127-10136.
15. Hazell, L.J., and R. Stocker. 1993. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:165-172.
16. Daugherty, A., B.S. Zweifel, B.E. Sobel, and G. Schonfeld. 1988. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 8:768-777.
17. Yla-Hertualla, S., W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum, and D. Steinberg. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-1095.
18. Steinbrecher, U.P., and M. Lougheed. 1992. Scavenger receptor independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima. Arterioscler. Thromb. 12:608-625.
19. Hazell, L.J., L. Arnold, D. Flowers, G. Waeg, F. Malle, and R. Stocker. 1996. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1535-1544.
20. Weiss, S.J., S.T. Test, C.M. Eckmann, D. Ross, and S. Regiani. 1986. Brominating oxidants generated by human eosinophils. Science (Wash. DC). 234:200-203.
21. - system. Eur. J. Biochem. 92:301-308.
22. Thomas, E.L., M.B. Grisham, and M.M. Jefferson. 1986. Preparation and characterization of chloramines. Methods Enzymol. 132:569-585.
23. Domigan, N.M., T.S. Charlton, M.W. Duncan, C.C. Winterbourn, and A.J. Kettle. 1995. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J. Biol. Chem. 270:16542-16548.
24. Kettle, A.J. 1995. Neutrophils convert tyrosine residues in albumin to chlorotyrosine. FEBS Lett. 379:103-106.
25. Hazen, S.L., F.F. Hsu, D.M. Mueller, J.R. Crowley, and J.W. Heinecke. 1996. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J. Clin. Invest. 98:1283-1289.
26. El-Saadani, M., H. Esterbauer, M. El-Sayad, M. Goher, A.Y. Nassar, and G. Jurgens. 1989. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:627-630.
27. Heinecke, J.W., W. Li, G.A. Francis, and J.A. Goldstein. 1993. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative crosslinking of proteins. J. Clin. Invest. 91:2866-2872.
28. Rakita, R.M., B.R. Michel, and H. Rosen. 1990. Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system. Biochemistry. 29:1075-1080.
29. Morita, Y., H. Iwamoto, S. Aibara, T. Kobayashi, and E. Hasegawa. 1986. Crystallization and properties of myeloperoxidase from normal human leukocytes. J. Biochem. 99:761-770.
30. Hazen, S.L., F.F. Hsu, and J.W. Heinecke. 1996. p-Hydroxyphenylacetaldehyde is the major product of L-tyrosine oxidation by activated human phagocytes: a chloride-dependent mechanism for the conversion of free amino acids into reactive aldehydes by myeloperoxidase. J. Biol. Chem. 271:1861-1867.
31. Markwell, M.A., S.M. Haas, L.L. Bieber, and N.E. Tolbert. 1978. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 87:206-210.
32. Nelson, D.P., and L.A. Kiesow. 1972. Enthalpy of decomposition of hydrogen peroxide by catalase at 25°C. Anal. Biochem. 49:474-478.
33. Heinecke, J.W., L. Suziki, H. Rosen, and A. Chait. 1987. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J. Biol. Chem. 262:10098-10103.
34. Rankin, S.M., S. Parthasarathy, and D. Steinberg. 1991. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J. Lipid Res. 32:449-456.
35. PDAY Research Group. 1993. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY study. Arterio. Thromb. 13:1291-1298.
36. Leeuwenburgh, C., M.M. Hardy, S.L. Hazen, P. Wagner, S. Oh-ishi, U.P. Steinbrecher, and J.W, Heinecke. 1997. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. J. Biol. Chem. 272:1433-1436.
37. 4. Nature (Lond.). 227:680-685.
38. Krull, E.S., J. Tang, T.S. Kettler, R.E. Clouse, and G. Schonfeld. 1992. Lengths of truncated forms of apolipoprotein B (apo B) determine their intestinal production. Biochem. Biophys. Res. Commun. 189:1069-1076.
39. Knapp, D.R. 1979. Handbook of Analytical Derivitization Reactions. John Wiley & Sons, New York.
40. Eiserich, J.P., C.E. Cross, A.D. Jones, B. Halliwell, and A. van der Vleit. 1996. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: a novel mechanism for nitric oxide-mediating protein modification. J. Biol. Chem. 271:19199-19208.
41. Hazell, L.J., J.J.M. van den Berg, and R. Stocker. 1994. Oxidation of low density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than by lipid oxidation. Biochem. J. 302: 297-304.
42. Hazen, S.L., F.F. Hsu, K. Duffin, and J.W. Heinecke. 1996. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 271:23080-23088.
43. Chisolm, G.M., G. Ma, K.C. Irwin, L.L. Martin, K.G. Gunderson, L.F. Linberg, D.W. Morel, and P.E. DiCorleto. 1994. 7-Beta-hydroxyperoxy cholest-5-en-3 beta-ol, a component of human atherosclerotic lesions, is the primary cytotoxin of oxidized human low density lipoprotein. Proc. Natl. Acad. Sci. USA. 91:11452-11456.
44. Kandutsch, A.A., H.W. Chen, and H. Heiniger. 1978. Biological activity of some oxygenated sterols. Science (Wash. DC). 201:498-501.
45. Sevanian, A., and A.R. Peterson. 1986. The cytotoxic and mutagenic properties of cholesterol oxidation products. Food & Chemical Toxicology. 24: 1103-1110.
46. Smith, L.L., and B.H. Johnson. 1989. Biological activities of oxysterols. Free Rad. Biol. Med. 7:285-332.
47. Piedrafita, F.J., R.B. Molander, G. Vansant, E.A. Orlova, M. Pfahl, and W.F. Reynolds. 1996. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 271:14412-14420.
48. Zhao, W.G., A. Regmi, E.D. Austin, J.E. Braun, M. Racine, and G.E. Austin. 1996. Cis-elements in the promoter region of the human myeloperoxidase (MPO) gene. Leukemia. 10:1089-1103.
49. Keaney, J.F., and B. Frei. 1994. Antioxidant protection of low-density lipoprotein and its role in the prevention of atherosclerotic vascular disease. In Natural Antioxidants in Human Health and Disease. B. Frei, editor. Academic Press, Inc., San Diego, CA. 303-339.
50. Stadtman, E.R. 1992. Protein oxidation and aging. Science (Wash. DC). 257:1220-1224.
51. Ursine, F., and K.J.A. Davies. 1990. Protein Metabolism in Aging. H.L. Segal, editor. Wiley-Liss, New York. 373-380.
52. Francis, G.A., A.J. Mendez, E.L. Bierman, and J.W. Heinecke. 1993. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc. Natl. Acad. Sci. USA. 90:6631-6635.
53. Lymar, S.V., and J.K. Hurst. 1995. Role of compartmentation in promoting toxicity of leukocyte-generated strong oxidants. Chem. Res. Toxic. 8: 833-840.